Bullous Pemphigoid Following IgG/IgA Pemphigus: Possible Involvement of SGLT2 and DPP-4 Inhibitors

Ayano Ikeda, Naomi Tani, Norito Ishii, Hiroshi Koga, Yuichi Yoshida · 2026

Read Bullous Pemphigoid Following IgG/IgA Pemphigus: Possible Involvement of SGLT2 and DPP-4 Inhibitors by Ayano Ikeda, Naomi Tani, Norito Ishii, Hiroshi Koga, Yuichi Yoshida (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13254163.txt.

Description

Ayano Ikeda and colleagues report a layered blistering skin case in a 2026 case report. A 60-year-old woman developed redness and blisters on her back and upper arms. Tests confirmed IgG/IgA pemphigus, a rare blistering disease where the immune system attacks skin cell links, with antibodies to desmoglein 1.

During her course, she later developed bullous pemphigoid, a second blistering disease. She had taken two diabetes drugs, linagliptin for six years and tofogliflozin for five months. A drug stimulation test was positive for tofogliflozin and negative for linagliptin, so the authors consider possible drug involvement in the second disease.

Catalog record

CREATORAyano Ikeda, Naomi Tani, Norito Ishii, Hiroshi Koga, Yuichi Yoshida
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE8952
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13254163

Browse the full library · About the Tower of Babel